EL vs LXEO · rev $15.05B vs $147.7M cap
Estee Lauder Companies Inc (EL) versus Lexeo Therapeutics, Inc. Common Stock (LXEO) — a side-by-side from cached financials, not a winner call.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
LXEO does not have a complete income-statement cache yet.
EL currently screens at market cap $31.92B. LXEO currently screens at market cap $147.7M.
Not investment advice. Open the EL and LXEO stock pages for the full models.
Not investment advice.